Literature DB >> 24688182

Impact of a surveillance screening program on rates of methicillin-resistant Staphylococcus aureus infections with a comparison of surgical versus nonsurgical patients.

Andrew Jennings1, Monica Bennett1, Tammy Fisher1, Alan Cook1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infection. The overall effectiveness of surveillance screening programs is not well established. A retrospective cohort study was performed to evaluate the impact of a surveillance screening program on the rates of health care-associated MRSA infection (HA-MRSA-I) at a single institution. A subset of surgical patients was analyzed separately. Multivariate regression techniques were used to identify predictors of the desired outcomes. The overall MRSA infection rate was 1.3% in the before cohort and 3.2% in the after cohort. After excluding patients with a history of MRSA infection or MRSA colonization, HA-MRSA-I decreased from 1.2% to 0.87%. There was a similar overall increase in the surgical group, 1.4% to 2.3%, and decrease in HA-MRSA-I, 1.4% to 1.0% (P < 0.001). For all patients, surgery, African American race, and increased length of stay conferred an increased likelihood of HA-MRSA-I. Females and patients in the after cohort had a lower risk of HA-MRSA-I (P < 0.01). In the after cohort, the results were similar, with surgery, African American race, and length of stay associated with an increased risk, and female sex associated with a decreased risk (P < 0.05). African American race and increased age had a higher likelihood of screening positive for MRSA colonization, while the surgical group, females, and Hispanic patients were less likely (P < 0.05). HA-MRSA-I was associated with a higher mortality among all patients (P < 0.001). Mortality rates were similar with HA-MRSA-I for all patients (10.8% vs 9.5%, P = 0.55) and in the surgical group (8.3% vs 6.8%, P = 0.58). In conclusion, surveillance programs may be effective in decreasing HA-MRSA-I. Further studies are needed to determine how to reduce transmission, particularly among African Americans and those with increased lengths of stay.

Entities:  

Year:  2014        PMID: 24688182      PMCID: PMC3954652          DOI: 10.1080/08998280.2014.11929064

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  19 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

2.  Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants.

Authors:  Rupak Datta; Richard Platt; Deborah S Yokoe; Susan S Huang
Journal:  Arch Intern Med       Date:  2011-03-28

3.  Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.

Authors:  Robertino M Mera; Jose A Suaya; Heather Amrine-Madsen; Cosmina S Hogea; Linda A Miller; Emily P Lu; Daniel F Sahm; Patrick O'Hara; Camilo J Acosta
Journal:  Microb Drug Resist       Date:  2011-03-19       Impact factor: 3.431

4.  The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus.

Authors:  S Thomas; S Cantrill; D J Waghorn; A McIntyre
Journal:  Aliment Pharmacol Ther       Date:  2007-03-01       Impact factor: 8.171

Review 5.  A review of the evidence for suboptimal compliance of healthcare practitioners to standard/universal infection control precautions.

Authors:  John Gammon; Heulwen Morgan-Samuel; Dinah Gould
Journal:  J Clin Nurs       Date:  2007-03-01       Impact factor: 3.036

6.  Health care-associated invasive MRSA infections, 2005-2008.

Authors:  Alexander J Kallen; Yi Mu; Sandra Bulens; Arthur Reingold; Susan Petit; Ken Gershman; Susan M Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; William Schaffner; Priti R Patel; Scott K Fridkin
Journal:  JAMA       Date:  2010-08-11       Impact factor: 56.272

Review 7.  Epidemiology of staphylococcal resistance.

Authors:  Andrew F Shorr
Journal:  Clin Infect Dis       Date:  2007-09-15       Impact factor: 9.079

8.  Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  R L Thompson; I Cabezudo; R P Wenzel
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

9.  MRSA nasal colonization burden and risk of MRSA infection.

Authors:  Edward Stenehjem; David Rimland
Journal:  Am J Infect Control       Date:  2012-12-20       Impact factor: 2.918

10.  Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Authors:  Stijn I Blot; Koenraad H Vandewoude; Eric A Hoste; Francis A Colardyn
Journal:  Arch Intern Med       Date:  2002-10-28
View more
  2 in total

1.  Intranasal octenidine and universal antiseptic bathing reduce methicillin-resistant Staphylococcus aureus (MRSA) prevalence in extended care facilities.

Authors:  A Chow; P Y Hon; G Tin; W Zhang; B F Poh; B Ang
Journal:  Epidemiol Infect       Date:  2018-09-04       Impact factor: 4.434

2.  Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.

Authors:  Jessica E Ericson; Victor O Popoola; P Brian Smith; Daniel K Benjamin; Vance G Fowler; Daniel K Benjamin; Reese H Clark; Aaron M Milstone
Journal:  JAMA Pediatr       Date:  2015-12       Impact factor: 26.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.